SUMMARY -Spinal metastatic disease is a rather common occurrence and defi nitely warrants attention and treatment due to the high likelihood of leaving cancer patients severely disabled in their fi nal months of life. Recent developments in the understanding of the behavior of diff erent tumor types, as well as advances in surgical treatment, are allowing for the evolution of treatment algorithms, especially when surgical treatment is to be considered. Th is paper gives an overview of the decisionmaking process and the array of surgical options currently available.
Introduction
Th e purpose of this article is to give an overview of the approach to treating spinal column metastases in cancer patients. Th is is a complex fi eld which requires thorough understanding of all treatment modalities available and decisions must be guided by a rational framework based on a number of parameters.
Spinal metastases are by no means an uncommon phenomenon, as virtually any malignant tumor type has the potential to metastasize to bone, with the spine being the predominant bony site 1 . Since some form of bony metastasis is almost to be expected in advanced stage malignant disease, it may be discovered through targeted screening using any of a number of diagnostic modalities (CT/PET-CT, MRI, bone scan). However, in case of an unknown primary tumor, symptoms from the metastases may be the fi rst signs of any illness. In this case, there are many 'red fl ags' which have been described to help guide the need for spinal malignancy screening 2 . Although none of these red fl ags except for prior history of cancer carried much weight as a warning sign, careful use of combinations of red fl ags can be of benefi t (age over 50, pain not relieved after a month of rest, thoracic pain which is worse at night, unexplained weight loss, generally poor state of health, etc.) 2 . It must be borne in mind that the goals of treatment of spinal metastases diff er from the goals of treating primary tumors considering that treatment is seldom curative. In metastatic cases, surgeons strive to improve the overall quality of life in a patient otherwise undergoing treatment for their primary tumor by decreasing pain, relieving neurological impairment, providing stability, and increasing patient independence 1 . Non-surgical treatment includes chemotherapy, radiotherapy, hormonal therapy (for example, in breast and prostate tumors), angiography and embolization (in highly vascular metastases, including renal cell, thyroid, melanoma, giant cell tumors, and hepatocellular carcinomas), and symptom management. Radiotherapy is often used with or without surgery and must be considered where histopathology of the primary tumor is one of known radiosensitivity (breast, prostate, Wilm's tumor, Ewing's sarcoma, lymphoma, seminoma, multiple myeloma, medulloblastoma, etc.), although even in relatively radioresistant histologies Surgery can also have an important role in cases in which it is deemed feasible. Surgical treatment is, of course, not without its own risks to the patient and benefi ts of the selected treatment modality must always outweigh the risks to the patient. It has long been held as general consensus that minimal life expectancy of 3 to 6 months is the minimum requirement for considering a major surgery 4 . However, in shorter life expectancies, palliative surgical procedures (kyphoplasty, vertebroplasty, placement of a morphine pump) could be benefi cial notwithstanding the morbidity they present 5 . In order to help systematize the decision-making process, several classifi cation scoring systems, as well as treatment algorithms have been developed which take into account parameters such as primary tumor histopathology, severity of impairment, overall wellbeing, and likelihood to receive any benefi t from surgery.
Harrington has proposed the treatment algorithm shown in Table 1 solely based on the amount of vertebral destruction and instability 6, 7 . Enneking, Tomita, and Weinstein/Boriani/Biagini describe patterns of tumor spread throughout a vertebra 8 . Th e Tokuhashi scoring system shown in Table 2 is one of the commonly used tools for treatment guidance 9, 10 . It takes into account the general state of the patient as evaluated by the Karnofsky performance score (shown in Table 3 ), the number of local (spinal), extraspinal and visceral metastases, tumor histology, and neurological status according to Frankel (summarized in Table 4 ). However, the modifi ed Bauer score has been shown to be a simpler system because it considers only the parameters which have been shown to mostly infl uence prognosis (shown in Table 5) 11 . It is reasonable to consider combining several systems in order to synthesize fi nal decision. For example, by using the Harrington principles, the Spinal Instability Neoplastic Score (SINS) ( Table 6 ), Tomita type 12 , and Tokuhashi score together, one can more confi dently determine the best course of action for a given patient.
According to histologic subtypes, tumors can be classifi ed into (1) slow growing (breast, prostate, carcinoid, thyroid), (2) moderately growing (kidney, uterus), and (3) rapidly growing (lung, liver, stomach, esophagus, pancreas, sarcomas, bladder) tumors 13 . 
Surgical Techniques
Before the advent of surgical treatment for metastatic spine disease, the standard treatment options were radiotherapy and corticosteroid application. Surgical treatment for spinal metastases fi rst received confi rmation of effi cacy by Patchell et al., who were the fi rst to demonstrate in a randomized prospective study that patients that were surgically decompressed clearly showed better results than those undergoing only palliative radiotherapy without decompression 14 . Since then, various criteria have been developed for the selection of patients that would benefi t most from surgical treatment 9, 13 . Th e degree of spinal cord compression has been better defi ned 15 , a framework has been established for considering spinal instability brought about by malignant disease 16 , and most recently, the required extent of treatment has been better defi ned 17 . Th us, spinal surgery has established its place within the complex, multidisciplinary and palliative approach to patients with spinal metastatic disease. Th e goals of surgical treatment of spinal metastases are local control of tumor size, pain reduction, maintaining motor function and sphincter control, prevention of deformity, and upgrading the quality of remaining lifetime.
However, before deciding on surgical treatment of spinal metastatic disease, it is imperative to know the histology of the specifi c tumor and the overall spread of the malignant disease, as these are the most important predictors of survival. Th erefore, biopsy should be the fi rst step to surgical treatment. Biopsy can be performed percutaneously by needle in local or general anesthesia and under control of an image intensifi er or by computerized tomography (Fig. 1) . If the result of such a biopsy should turn out negative for malignant cells and strong suspicion of malignancy remains, then open biopsy should be the next step.
Upon deciding on the need of surgical treatment, it may be necessary to perform preoperative embolization of the tumor in order to reduce intraoperative bleeding. Th is is especially important for histologic types which are prone to excess bleeding (for example, renal cell or thyroid cancer), as seen in Figure 2 .
Th e spinal surgeon has an array of treatment options that diff er in invasiveness and how radical the tumor resection should be 17 . Th e most radical operation is en bloc resection of a tumor according to the principles of treatment of primary spinal tumors 12 . Th ey are divided into 3 types of radical resections: vertebrectomy, sagittal resection of a vertebra, and total resection of posterior elements 8 . Th e indication for such a procedure would be a controllable histologic type of tumor, the presence of a metastasis that is technically resectable with a surrounding layer of healthy tissue, the lack of other distant metastases, and a generally good overall state of the patient (Fig. 3) . with stabilization of the spinal column. Th ese procedures are less radical than en bloc resections, although they may yield virtually identical results if stereotactic radiosurgery (which has signifi cantly altered the treatment approach to patients with spinal metastases) is additionally performed 19 . Th e goal of modern surgery in metastatic spine disease is to ensure suffi cient distancing of the tumor from the spinal cord (separational surgery) and to provide stable fi xation of the spinal column to allow for safe application of radiotherapy on the whole tumor volume.
In the case of spinal instability and great pain, which would hinder upright posture and/or ambulation in the patient, there are several ways in which stabilization can be achieved. Stabilization is indicated when there is a clear risk of instability according to the SINS score, re- gardless of histologic tumor type and overall predicted survival, provided that the general state of the patient allows for surgery to be performed, some examples of which can be seen in Figure 4 14 . Stabilization methods include open anterior and posterior stabilization, percutaneous stabilization methods, and vertebroplasty or kyphoplasty 20 . Minimally invasive methods for stabilization of the vertebral body are particularly convenient as palliative techniques for patients who otherwise would not be candidates for radical surgery, such as patients with multilevel involvement (Fig. 5) 
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. Percutaneous stabilization of the spine is indicated in patients in whom there is clear instability without signifi cant spinal cord compression (Fig. 6) 
22
. In the case that the expected remaining lifespan of the patient is under 3 months and there are multiple metastatic changes along the spinal column and unbearable pain that is unresponsive to high doses of opioid analgesics, it is recommended to install an intrathecal opioid pump to be able to control pain with much lower doses of opioids and fewer complications (Fig. 7) . 
Conclusion
Patients with spine metastases frequently present with complex diagnostic and therapeutic challenges requiring an integrated multi-step approach and multidisciplinary care, including a team of surgeons and oncologists. In managing these patients, every eff ort should be made to provide an early diagnosis and appropriate treatment for preservation of neurological function and quality of remaining life. Unfortunately, diagnosis is frequently not established until signifi cant neurological defi cit is present, by which time functional recovery may be unlikely. Newer surgical techniques that address decompression, spinal stabilization, with or without tumor resection, and minimally invasive pain relieving strategies must be taken into consideration in surgical candidates. Studies have shown clear benefi t of surgical management in terms of maintaining ambulation and sphincter control, as well as in providing pain relief and prolonging patient independence. Although surgical intervention will not decrease mortality, it should nonetheless be strongly considered in patients that fulfi ll the established criteria for a reasonable outcome.
